MENU
+Compare
ABEO
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$5.38
Change
+$0.17 (+3.26%)
Capitalization
263.03M

ABEO Abeona Therapeutics Forecast, Technical & Fundamental Analysis

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ABEO with price predictions
Apr 23, 2025

ABEO in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 31, 2025

ABEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where ABEO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ABEO's RSI Indicator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on ABEO as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABEO just turned positive on April 14, 2025. Looking at past instances where ABEO's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

ABEO moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABEO advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABEO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ABEO entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.974) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (30.303) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABEO is expected to report earnings to fall 174.50% to -37 cents per share on May 08

Abeona Therapeutics ABEO Stock Earnings Reports
Q1'25
Est.
$-0.37
Q4'24
Beat
by $0.85
Q3'24
Missed
by $0.24
Q2'24
Beat
by $0.07
Q1'24
Missed
by $0.65
The last earnings report on March 20 showed earnings per share of 50 cents, beating the estimate of -34 cents. With 1.34M shares outstanding, the current market capitalization sits at 263.03M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
6555 Carnegie Avenue
Phone
+1 646 813-4701
Employees
84
Web
https://www.abeonatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIRTX23.89N/A
N/A
Nuveen Large Cap Growth A
FEVCX19.31N/A
N/A
First Eagle US C
PPYPX7.98N/A
N/A
PIMCO RAE International I-2
SDVRX22.24N/A
N/A
PGIM Quant Solutions Mid-Cap Val R
AFOCX21.42N/A
N/A
Archer Focus

ABEO and Stocks

Correlation & Price change

A.I.dvisor tells us that ABEO and RZLT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABEO and RZLT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
-1.14%
RZLT - ABEO
31%
Poorly correlated
+27.65%
AXON - ABEO
31%
Poorly correlated
+3.82%
MLEC - ABEO
29%
Poorly correlated
-9.65%
SCPH - ABEO
29%
Poorly correlated
-0.77%
XNCR - ABEO
29%
Poorly correlated
+2.07%
More